Victoria Nambasa

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis

Eric Pelfrene, Martin Harvey Allchurch, Nsengi Ntamabyaliro et al. · PLoS neglected tropical diseases · 2019 · 41 citations · Full text

Human African Trypanosomiasis, Antiparasitic Agent, Medicine +7

The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study

Helen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza et al. · Drug Safety · 2018 · 31 citations · Full text

Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in Uganda

Helen Byomire Ndagije, Victoria Nambasa, Elizabeth Namagala et al. · Drug Safety · 2015 · 23 citations · Full text

Adverse Drug Reaction Onsets in Uganda’s VigiBase®: Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses

Ronald Kiguba, Helen Byomire Ndagije, Victoria Nambasa et al. · Pharmaceutical Medicine · 2018 · 15 citations · Full text

Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance

Victoria Nambasa, Helen Byomire Ndagije, Allan Serwanga et al. · Antibiotics · 2020 · 15 citations · Full text